Rescue therapy with interleukin-2 receptor antibody in high risk kidney transplant patients: a 3-year follow-up study.
Carl
S
S
Department of Urology, University of Heidelberg, Germany.
Wiesel
M
M
Daniel
V
V
Dörsam
J
J
Opelz
G
G
Staehler
G
G
D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000473:pathology / Q000517:prevention & control / Q000628:therapy*; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D015375:Receptors, Interleukin-2 / Q000276:immunology*; D018570:Risk Assessment
D000911:Antibodies, Monoclonal; D015375:Receptors, Interleukin-2; C079843:inolimomab